Impaired systemic endothelial function in patients with pseudoexfoliation syndrome

International Heart Journal

Volumn 47, Issue 1, 2006, Pages 77-84

  Atalar, Pinar Tuna ^a   Atalar, Enver ^a   Kilic, Harun ^a   Abbasoglu, Özlem E ^a   Ozer, Necla ^a   Aksöyek, Serdar ^a   Övünç, Kenan ^a   Ozmen, Ferhan ^a   Gürsel, Emin ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Endothelial dysfunction; Endothelium; Flow mediated dilation; Pseudoexfoliation syndrome

Indexed keywords

GLYCERYL TRINITRATE; VASODILATOR AGENT;

AGED; ARTICLE; BLOOD FLOW; BLOOD VESSEL REACTIVITY; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CUTANEOUS PARAMETERS; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; EXFOLIATION SYNDROME; FEMALE; GLAUCOMA; HUMAN; HYPEREMIA; MALE; PRIORITY JOURNAL; PSEUDOEXFOLIATION; VASCULAR ENDOTHELIUM; VASODILATATION; CASE CONTROL STUDY; DRUG EFFECT; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY;

AGED; BRACHIAL ARTERY; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; EXFOLIATION SYNDROME; FEMALE; HUMANS; MALE; MIDDLE AGED; NITROGLYCERIN; PROSPECTIVE STUDIES; VASODILATOR AGENTS;

EID: 33344462685     PISSN: 13492365     EISSN: None     Source Type: Journal    
DOI: 10.1536/ihj.47.77     Document Type: Article

References (23)

1. Ritch R, Schlotzer-Schrehardt U. Exfoliation syndrome. Surv Ophthalmol 2001; 45: 265-315. (Review)
2. Vesti A, Kivela T. Exfoliation syndrome and exfoliation glaucoma. Prog Retin Eye Res 2000; 19: 345-68. (Review)
3. Schlotzer-Schrehardt UM, Koca MR, Naumann GO, Volkholz H. Pseudoexfoliation syndrome. Ocular manifestation of a systemic disorder? Arch Ophthalmol 1992; 110: 1752-6.
4. Streenten BW, Li ZY, Wallace RN, Eagle RC Jr, Keshgegian AA. Pseudoexfoliative fibrillopadly in visceral organs of a patient with pseudoexfoliation syndrome. Arch Ophthalmol 1992; 110: 1757-62.
5. Schumacher S, Schlotzer-Schrehardt U, Martus P, Lang W, Naumann GO. Pseudoexfoliation syndrome and aneurysms of the abdominal aorta. Lancet 2001; 357: 359-60.
6. Schlotzer-Schrehardt U, Kuchle M, Naumann Go. Electron-microscopic identification of pseudoexfoliation material in extrabulbar tissue. Arch Ophthalmol 1991; 109: 565-70.
7. Consentino F, Luscher TF. Endothelial dysfunction in diabetes mellitus. J Cardiovasc Pharmacol 1998; 32 (Suppl 3): S54-61. (Review)
8. Anderson TJ. Assessment and treatment of endothelial dysfunction in humans. J Am Coll Cardiol 1999; 34: 631-8. (Review)
9. Cheung YF, Chan GC, Ha SY Arterial stiffness and endothelial function in patients with beta-thalassemia major. Circulation 2002; 106: 2561-6.
10. Fathi R, Marwick TH. Noninvasive tests of vascular function and structure: why and how to perform them. Am Heart J 2001; 141: 694-701. (Review)
11. Coretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39: 257-65.
12. Joannides R, Haefeli WE, Linder L, et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995; 91: 1314-9.
13. Sezgin N, Barutcu I, Sezgin AT, el al. Plasma nitric oxide level and its role in slow coronary flow phenomenon. Int Heart J 2005; 46: 373-82.
14. Schlotzer-Schrebardt U, Kuchle M, Naumann GO. Electron-microscopic identification of pseudoexfoliation material in extrabulbar tissue. Arch Ophthalmol 1991; 109: 565-70.
15. Schlotzer-Schrehardt UM, Koca MR, Naumann GO, Volkholz H. Pseudoexfoliation syndrome. Ocular manifestation of a systemic disorder? Arch Ophthalmol 1992; 110: 1752-6.
16. Streen BW, Dark AJ, Wallace RN, Li ZY, Hoepner JA. Pseudoexfoliative fibrillopathy in the skin of patients with ocular pseudoexfoliation. Am J Ophthomol 1990; 110: 490-9.
17. Mitchell P, Wang JJ, Smith W. Association of pseudoexpoliation syndrome with increased vascular risk. Am J Ophthalmol 1997; 124:685-7.
18. Shrum KR, Hattenhauer MG, Hodge D. Cardiovascular and cerebrovascular mortality associated with ocular pseudoexfoliation. Am J Ophthalmol 2000; 129: 83-6.
19. Neunteufl T, Heher S, Katzenschlager R, et al. Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am J Cardiol 2000; 86: 207-10.
20. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000; 101: 1899-906.
21. Henry E, Newby DE, Webb DJ, O'Brien C. Peripheral endothelial dysfunction in normal pressure glaucoma. Invest Ophthalmol Vis Sci 1999; 40: 1710-4.
22. Becquet F, Courtois Y, Goureau O. Nitric oxide in the eye: multifaceted roles and diverse outcomes. Surv Ophthalmol 1997; 42: 71-82. (Review)
23. Haefliger IO, Flammer J, Luscher TF. Nitric oxide and endothelin-1 are important regulators of human ophthalmic artery. Invest Ophthalmol Vis Sci 1992; 33: 2340-3.